Compare RNXT & INLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | RNXT | INLX |
|---|---|---|
| Founded | 2012 | 1996 |
| Country | United States | United States |
| Employees | N/A | 98 |
| Industry | Biotechnology: Pharmaceutical Preparations | EDP Services |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 37.0M | 30.4M |
| IPO Year | 2021 | 2013 |
| Metric | RNXT | INLX |
|---|---|---|
| Price | $0.82 | $7.30 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $8.25 | N/A |
| AVG Volume (30 Days) | ★ 263.2K | 1.5K |
| Earning Date | 05-14-2026 | 05-14-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 20.00 | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $1,123,000.00 | $11,336.00 |
| Revenue This Year | $194.66 | $16.86 |
| Revenue Next Year | $279.78 | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ 2511.63 | N/A |
| 52 Week Low | $0.70 | $6.76 |
| 52 Week High | $1.45 | $14.57 |
| Indicator | RNXT | INLX |
|---|---|---|
| Relative Strength Index (RSI) | 37.44 | 41.86 |
| Support Level | $0.81 | N/A |
| Resistance Level | $1.07 | $8.40 |
| Average True Range (ATR) | 0.05 | 0.23 |
| MACD | -0.00 | 0.00 |
| Stochastic Oscillator | 11.42 | 16.15 |
RenovoRx Inc is a clinical-stage biopharmaceutical company developing proprietary targeted combination therapies for high unmet medical need with a goal to improve therapeutic outcomes for cancer patients undergoing treatment. RenovoRx's patented Trans-Arterial Micro-Perfusion therapy platform is designed to ensure precise therapeutic delivery to directly target the tumor while potentially minimizing a therapy's toxicities versus systemic intravenous therapy.
Intellinetics Inc is a document service and solutions software company serving both the small-to-medium business and governmental sectors. The company's digital transformation products and services are provided through two reporting segments: Software and Document Services. The Software segment consists of solutions involving software platforms, which allow customers to capture and manage all documents across operations such as scanned hard-copy documents and all digital documents including those from Microsoft Office 365, digital images, audio, video, and emails. The company's Document Services offerings aid clients as a part of their overall document to convert documents from one medium to another. Majority of revenue is from Document Services Segment.